Topic: profits

Merck CEO Kenneth Frazier worries new JAMA studies on pharma profitability ill exacerbate the ongoing political debate about drug pricing.

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.

@FiercePharma: NIAID scientists one step closer to 'universal' flu vaccine. More | Follow @FiercePharma @CarlyHFierce: Earnings season is better than Christmas. I mean, I actually like most...

@FiercePharma: Merck JV signs on Bangladeshi firms to speed low-cost cholera candidate. More | Follow @FiercePharma @EricPFierce: Cadilia gets slapped with #FDA warning for not following up on...

@FiercePharma: Pharma tension rises in China as officials fine J&J, visit Sanofi; AZ chief anticipates pricing moves. News | Follow @FiercePharma @CarlyHFierce: Price controls in India...

@FiercePharma: AZ's dental unit attracts a slew of suitors. Story | Follow @FiercePharma > Celgene has agreed to pay Elan $78 million to settle a patent infringement lawsuit over the Celgene

Celegene could get a big boost from new data set to be reported next week. Revlimid, its best-selling multiple myeloma pill, could emerge as a first-line treatment rather than Johnson & Johnson's